Outputs (139)

Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis (2023)
Journal Article
Hussain, B., Malik, H., Mamas, M. A., Desai, R., Aggarwal, V., Kumar, G., …Paul, T. K. (2023). Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis. Journal of the Society for Cardiovascular Angiography & Interventions, Article 101267. https://doi.org/10.1016/j.jscai.2023.101267

Background
Infiltrative diseases (ID), including amyloidosis, sarcoidosis, and hemochromatosis comprise a wide spectrum of disorders characterized by abnormal cellular infiltration in multiple organs, including th... Read More about Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis.

Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials. (2023)
Journal Article
Rivera, F. B., Cha, S. W., Aparece, J. P., Jariyatamkitti, S., & Mamas, M. (in press). Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials. Journal of Cardiovascular Pharmacology, 83(3), 265-270. https://doi.org/10.1097/FJC.0000000000001533

The role of colchicine for the prevention of postoperative atrial fibrillation (POAF) following cardiothoracic surgery is not well-established. We aimed to evaluate its potential in preventing POAF using data from randomized controlled trials (RCTs).... Read More about Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials..

RWD1 Capacity-Enhancing Innovation (CEI) and the Treatment of Severe Symptomatic Aortic Stenosis (sSAS) in England (2023)
Journal Article
Sarmah, A., Busca, R., & Mamas, M. (2023). RWD1 Capacity-Enhancing Innovation (CEI) and the Treatment of Severe Symptomatic Aortic Stenosis (sSAS) in England. Value in Health, 26(12), Article S504. https://doi.org/10.1016/j.jval.2023.09.2719

Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019 (2023)
Journal Article
Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre‐Finn, C., Morris, C., …Kontopantelis, E. (in press). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019. Cancer, https://doi.org/10.1002/cncr.35152

Background
Anticoagulation of patients with atrial fibrillation (AF) and cancer is challenging because of their high risk for stroke and bleeding. Little is known of the variations of oral anticoagulant (OAC) prescribing in patients with AF with and... Read More about Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019.

Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective (2023)
Journal Article
Sharp, A. S. P., Kinnaird, T., Curzen, N., Ayyub, R., Alfonso, J. E., Mamas, M. A., & Bavière, H. V. (in press). Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective. European Heart Journal - Quality of Care and Clinical Outcomes, https://doi.org/10.1093/ehjqcco/qcad073

Background
Use of intravascular ultrasound (IVUS) during percutaneous coronary intervention (PCI) is associated with improved clinical outcomes over angiography alone. Despite this, the adoption of IVUS in clinical practice remains low.

Aims
To... Read More about Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective.

European Society of Cardiology Core Curriculum for Cardio-Oncology. (2023)
Journal Article
López-Fernández, T., Farmakis, D., Ameri, P., Asteggiano, R., de Azambuja, E., Aznar, M., …Rosano, G. M. C. (in press). European Society of Cardiology Core Curriculum for Cardio-Oncology. European Journal of Heart Failure, 10.1002/ejhf.3102. https://doi.org/10.1002/ejhf.3102

Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant d... Read More about European Society of Cardiology Core Curriculum for Cardio-Oncology..

COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature. (2023)
Journal Article
Jaiswal, V., Mukherjee, D., Peng Ang, S., Kainth, T., Naz, S., Babu Shrestha, A., …Siller-Matula, J. M. (2023). COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature. IJC Heart & Vasculature, 49, 101280. https://doi.org/10.1016/j.ijcha.2023.101280

Background
Myocarditis secondary to Coronavirus Disease 2019 (COVID-19) vaccination has been reported in the literature.

Objective
This study aimed to characterize the reported cases of myocarditis after COVID-19 vaccination based on age, gender... Read More about COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature..

Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer. (2023)
Journal Article
Kobo, O., Abramov, D., Fiuza, M., Chew, N. W. S., Ng, C. H., Parwani, P., …Mamas, M. A. (in press). Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer. Journal of the American Heart Association, 12(23), Article e030942. https://doi.org/10.1161/JAHA.123.030942

Although individuals with cancer experience high rates of cardiovascular morbidity, there are limited data on the potential differences in cardiovascular health (CVH) metrics between individuals with and without cancer. The National Health and Nutrit... Read More about Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer..

Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study. (2023)
Journal Article
Pana, T. A., Mamas, M. A., Wareham, N. J., Khaw, K., Dawson, D. K., & Myint, P. K. (in press). Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study. European Journal of Preventive Cardiology, Article zwad283. https://doi.org/10.1093/eurjpc/zwad283

Better understanding of sex differences in cardiovascular disease (CVD) is essential in tailoring appropriate preventative strategies. Using a large population-based study with follow-up >25 years, we aimed to determine sex-specific lifetime risks of... Read More about Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study..

Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis (2023)
Journal Article
Yong, J. H., Mai, A. S., Matetić, A., Elbadawi, A., Elgendy, I. Y., Lopez-Fernandez, T., & Mamas, M. A. (2024). Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis. The American Journal of Cardiology, 212, 80-102. https://doi.org/10.1016/j.amjcard.2023.11.039

Patients with haematological malignancies (HM) are at risk of future cardiovascular (CV) events. We therefore conducted a systematic review and meta-analysis to quantify their risk of future CV events. We searched Medline and Embase databases from in... Read More about Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis.